Tumors
WASHINGTON - Follow-up studies of a Roche breast cancer drug showed that it failed to extend the lives of patients, federal health scientists said Friday, opening the door for it to be potentially withdrawn for use in treating that disease.
WASHINGTON - A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval Thursday, offering an important alternative to more taxing treatments like chemotherapy.
